Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Merus N.V. CS (MRUS)

Merus N.V. CS (MRUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates

/CNW/ -- USA News Group – Pancreatic cancer is among the deadliest cancers, prompting researchers to focus on early detection to improve survival rates. Johns...

ONCY : 1.0300 (+3.15%)
HALO : 45.50 (-0.57%)
CADL : 3.97 (-0.25%)
MRUS : 48.01 (+11.83%)
RHHBY : 35.1300 (-0.79%)
ONC.TO : 1.40 (-5.41%)
Biotech Innovations Poised to Transform Pancreatic Cancer Treatment and Patient Outcomes

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – Pancreatic cancer is among the...

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)
RHHBY : 35.1300 (-0.79%)
HALO : 45.50 (-0.57%)
CADL : 3.97 (-0.25%)
MRUS : 48.01 (+11.83%)
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates

/CNW/ -- USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic...

ONCY : 1.0300 (+3.15%)
CADL : 3.97 (-0.25%)
AZN : 63.74 (+0.85%)
MRUS : 48.01 (+11.83%)
LTRN : 2.94 (-4.55%)
ONC.TO : 1.40 (-5.41%)
Biotech Developers Pioneer New Treatments, Aiming to Reduce Pancreatic Cancer Fatalities in 2024

USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic cancer patients through earlier detection, as according...

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)
CADL : 3.97 (-0.25%)
AZN : 63.74 (+0.85%)
MRUS : 48.01 (+11.83%)
LTRN : 2.94 (-4.55%)
Pancreatic Cancer Battle Intensifies with Biotech Sector's Advanced Treatments

USA News Group – A new study is bringing hope in the fight against one of the deadliest cancers, revealing a blood test that can detect early-stage pancreatic cancer with 97% accuracy. This breakthrough...

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)
RHHBY : 35.1300 (-0.79%)
MRUS : 48.01 (+11.83%)
MGNX : 3.28 (-5.75%)
IMRX : 1.99 (-2.32%)
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:PYXS),(NASDAQ:AZN),(NYSE:LLY),(NASDAQ:MRUS) EQNX::TICKER_END

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)
PYXS : 2.28 (-40.31%)
AZN : 63.74 (+0.85%)
LLY : 752.40 (-0.13%)
MRUS : 48.01 (+11.83%)
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review

/PRNewswire/ -- USA News Group - Since September 2022, the US Food and Drug Administration (FDA) has seen new treatments for pancreatic cancer that are worthy...

ONC.TO : 1.40 (-5.41%)
ONCY : 1.0300 (+3.15%)
PYXS : 2.28 (-40.31%)
AZN : 63.74 (+0.85%)
LLY : 752.40 (-0.13%)
MRUS : 48.01 (+11.83%)
Breakthroughs in Pancreatic Cancer Treatment: How FDA Designations are Changing the Game

USA News Group – Since September 2022, the US Food and Drug Administration (FDA) has seen new treatments for pancreatic cancer that are worthy of further investigation or approval. Known as one of the...

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)
PYXS : 2.28 (-40.31%)
AZN : 63.74 (+0.85%)
LLY : 752.40 (-0.13%)
MRUS : 48.01 (+11.83%)
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases

/PRNewswire/ -- USA News Group - The seriousness of pancreatic cancer continues to grow, with increasing alarm since The Lancet published an analysis back in...

ONC.TO : 1.40 (-5.41%)
ONCY : 1.0300 (+3.15%)
MRUS : 48.01 (+11.83%)
GH : 30.90 (+0.72%)
MDT : 84.10 (-0.01%)
NVDA : 148.70 (+1.93%)
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 26, 2023 – USA News Group  –  The seriousness of pancreatic cancer continues to grow, with increasing alarm since...

ONCY : 1.0300 (+3.15%)
ONC.TO : 1.40 (-5.41%)
MRUS : 48.01 (+11.83%)
GH : 30.90 (+0.72%)
MDT : 84.10 (-0.01%)
NVDA : 148.70 (+1.93%)

Barchart Exclusives

Turning Point Brands Is Smoking!
Summary Turning Point Brands (TPB) has shown exceptional price appreciation, gaining 45.94% since the Trend Seeker buy signal on 9/19, with 100% technical buy signals. The company operates through three segments: Zig-Zag Products, Stoker's Products, and Creative Distribution Solutions, offering a diverse range of tobacco and non-tobacco products. Fundamental factors... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar